One of the core business areas of Cadila Pharmaceuticals is to synthesize Active Pharmaceutical Ingredients
APIs of the highest standard in an integrated cost effective manner.
Spread over 80,000 square meter area, ISO-9001 & ISO14001 API manufacturing
facility at Ankleshwar, India is accredited by USFDA, EDQM – European
Directorate of Quality Medicine, AIFA – Agenzia Italiana del Farmaco,
TGA – Theapeutic Goods Administration, Australia and WHO. The company
offers more than 38 APIs and intermediates which are
exported across the world. Having filed 29 USDMFs, CEP for 09 APIs and
with more in pipeline, the unit is committed to offer an unmatched
portfolio.
No comments:
Post a Comment